Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.

Pär Stattin; Herman Adlercreutz; Leena Tenkanen; Egil Jellum; Sonja Lumme; Göran Hallmans; Sverre Harvei; Lyly Teppo; Katariina Stumpf; Tapio Luostarinen; Matti Lehtinen; Joakim Dillner; Matti Hakama

doi:10.1002/ijc.10313

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.

Pär Stattin, Herman Adlercreutz, Leena Tenkanen, Egil Jellum, Sonja Lumme, Göran Hallmans, Sverre Harvei, Lyly Teppo, Katariina Stumpf, Tapio Luostarinen, Matti Lehtinen, Joakim Dillner, Matti Hakama

Clinical Microbiology, Malmö

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	124-129
Journal	International Journal of Cancer
Volume	99
Issue number	1
DOIs	https://doi.org/10.1002/ijc.10313
Publication status	Published - 2002

Subject classification (UKÄ)

Cancer and Oncology

Free keywords

Sweden: epidemiology
4-Butyrolactone: analogs & derivatives
4-Butyrolactone: blood
Case-Control Studies
Cohort Studies
Estrogens: blood
Finland: epidemiology
Non-U.S. Gov't
Fluoroimmunoassay
Human
Lignans: blood
Male
Middle Aged
Norway: epidemiology
Prospective Studies
Prostatic Neoplasms: blood
Prostatic Neoplasms: epidemiology
Risk Factors
Support

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ijc.10313

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11948503&dopt=Abstract

Cite this

@article{bc7672444f6340e098189371717d0ba2,

title = "Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.",

keywords = "Sweden: epidemiology, 4-Butyrolactone: analogs & derivatives, 4-Butyrolactone: blood, Case-Control Studies, Cohort Studies, Estrogens: blood, Finland: epidemiology, Non-U.S. Gov't, Fluoroimmunoassay, Human, Lignans: blood, Male, Middle Aged, Norway: epidemiology, Prospective Studies, Prostatic Neoplasms: blood, Prostatic Neoplasms: epidemiology, Risk Factors, Support",

author = "P{\"a}r Stattin and Herman Adlercreutz and Leena Tenkanen and Egil Jellum and Sonja Lumme and G{\"o}ran Hallmans and Sverre Harvei and Lyly Teppo and Katariina Stumpf and Tapio Luostarinen and Matti Lehtinen and Joakim Dillner and Matti Hakama",

year = "2002",

doi = "10.1002/ijc.10313",

language = "English",

volume = "99",

pages = "124--129",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley & Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.

AU - Stattin, Pär

AU - Adlercreutz, Herman

AU - Tenkanen, Leena

AU - Jellum, Egil

AU - Lumme, Sonja

AU - Hallmans, Göran

AU - Harvei, Sverre

AU - Teppo, Lyly

AU - Stumpf, Katariina

AU - Luostarinen, Tapio

AU - Lehtinen, Matti

AU - Dillner, Joakim

AU - Hakama, Matti

PY - 2002

Y1 - 2002

KW - Sweden: epidemiology

KW - 4-Butyrolactone: analogs & derivatives

KW - 4-Butyrolactone: blood

KW - Case-Control Studies

KW - Cohort Studies

KW - Estrogens: blood

KW - Finland: epidemiology

KW - Non-U.S. Gov't

KW - Fluoroimmunoassay

KW - Human

KW - Lignans: blood

KW - Male

KW - Middle Aged

KW - Norway: epidemiology

KW - Prospective Studies

KW - Prostatic Neoplasms: blood

KW - Prostatic Neoplasms: epidemiology

KW - Risk Factors

KW - Support

U2 - 10.1002/ijc.10313

DO - 10.1002/ijc.10313

M3 - Article

SN - 0020-7136

VL - 99

SP - 124

EP - 129

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 1

ER -